NEW YORK, Nov. 19, 2022 (GLOBE NEWSWIRE) —

Okta, Inc. OCTA

Lifshitz Law PLLC announces that a class action lawsuit has been filed on behalf of Okta shareholders alleging that the defendants made materially false and misleading statements regarding the Company’s business, operations and compliance policies. Specifically, the Defendants made false and/or misleading statements and/or failed to disclose that: (i) Okta had inadequate cybersecurity controls; (ii) as a result, Okta’s systems were vulnerable to data breaches; (iii) Okta ultimately experienced a data breach caused by a hacking group that potentially affected hundreds of Okta customers; (iv) Okta initially failed to disclose and subsequently downplayed the seriousness of the data breach; (v) any of these, once known, would be likely to have a material adverse effect on Okta’s business, financial condition and reputation; and (vi) as a result, the Company’s public statements have been materially false and misleading at all relevant times.

If you are an Okta investor and would like additional information about our research, please fill out Information Request Form or contact Joshua Lifshitz, Esq. by phone at (516) 493-9780 or by email info@jlclasslaw.com.

CorMedix, Inc. CRMD

Lifshitz Law PLLC announces that a class action lawsuit has been filed on behalf of CorMedix shareholders alleging that the defendants made materially false and/or misleading statements and failed to disclose material adverse facts about the Company’s business, operations and prospects . Specifically, the Complaint alleges that the Defendants made material misstatements and/or failed to disclose: (i) deficiencies related to the DefenCath manufacturing process and/or the facility responsible for DefenCath manufacture; (ii) given the foregoing deficiencies, the FDA was unlikely to approve the DefenCath NDA for CRBSIs in its current form; (iii) Defendants had discovered the true scope of the…